U.S. Markets closed

Humana Inc. (HUM)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
379.65-0.94 (-0.25%)
At close: 4:06PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close380.59
Open383.61
Bid382.86 x 800
Ask380.43 x 900
Day's Range379.00 - 390.03
52 Week Range208.25 - 474.70
Volume1,284,783
Avg. Volume1,071,231
Market Cap48.922B
Beta (5Y Monthly)0.85
PE Ratio (TTM)15.00
EPS (TTM)25.31
Earnings DateApr 28, 2021
Forward Dividend & Yield2.80 (0.74%)
Ex-Dividend DateMar 30, 2021
1y Target Est477.71
  • GuruFocus.com

    A Trio of Stocks with Low 12-Month and Forward PEG Ratios

    These could be bargain opportunities

  • Humana (HUM), Mercy Tie Up to Extend Telehealth Services
    Zacks

    Humana (HUM), Mercy Tie Up to Extend Telehealth Services

    Humana (HUM) partners with Mercy to expand virtual care services for members.

  • Humana, Mercy Partner On Virtual Health Service Access Expansion; Street Says Buy
    SmarterAnalyst

    Humana, Mercy Partner On Virtual Health Service Access Expansion; Street Says Buy

    Humana is partnering with Mercy to expand patient access to virtual health services. This is part of a broader effort by the two companies to enable more holistic care for Humana Medicare Advantage (HMA) members. Humana’s (HUM) regional Medicare President Jeremy Gaskill said, “This agreement unites two organizations striving to offer care that is more accessible, personalized, and coordinated- a commitment that is more important than ever right now.” Meanwhile, Mercy’s Executive Vice President, Chief Strategist, and CFO Shannon Sock said, “Strong payor relationships, like this one with Humana, will help in our long-term journey to provide more seamless care for our patients.” This value based agreement expands the two companies’ current contract, which provides in network access at all of Mercy’s hospitals, outpatient facilities and physician practices. It also provides convenient care options for HMA members who are also patients of Mercy’s 4,000-plus primary and specialty care clinicians. At the end of 2020, Humana had upwards of 2.7 million individual Medicare Advantage and commercial members. Its total Medicare Advantage membership stands at more than 4.8 million. The primary aspects of this joint effort are Mercy Virtual and value-based care. Mercy Virtual, called “hospital without beds,” offers 24/7 care to patients when and where they need it. Under value-based care, the payment to Mercy’s physicians is linked to quality care to improve outcomes and experience. It differs from the current norm of “fee for service” models, where payment is based on the quantity of services provided. (See Humana stock analysis on TipRanks) On Feb. 4, Oppenheimer analyst Michael Wiederhorn reiterated a Buy rating and a price target of $460 (20.9% upside potential) on the stock. Commenting on Humana’s 4Q performance, Wiederhorn said, “The results reflect the offsetting impacts from the increase in COVID (higher treatment/testing costs, offset by lower non-COVID utilization).” He added, “Humana remains well positioned for 2021.” Turning to Wall Street, Humana has a Strong Buy consensus rating based on 7 Buys and 1 Hold. The average analyst price target of $474.88 implies about 24.8% upside potential from current levels. Humana stock has seen a gain of about 15% over the past year. Related News: Beyond Meat Posts Mixed 4Q Results; Street Says Hold Moderna 4Q Revenues Jump To $571M On Back Of COVID-19 Vaccine; Shares Rise 4% Tesla Confirms Fremont Factory Restart After Parts Supply Shortage – Report More recent articles from Smarter Analyst: Rocket Gains 6.8% On Special Dividend Announcement After A Blowout Quarter Salesforce Posts Strong 4Q Earnings But FY22 Guidance Disappoints; Shares Drop 4.8% LHC Group Slips 5.9% After-Hours On Tepid 1Q Outlook Arcosa’s 2021 Revenue Outlook Disappoints After 4Q Miss; Stock Plunges 16%